Cargando…
PTPRD and DCC Are Novel BACE1 Substrates Differentially Expressed in Alzheimer’s Disease: A Data Mining and Bioinformatics Study
The β-site Amyloid precursor protein Cleaving Enzyme 1 (BACE1) is an extensively studied therapeutic target for Alzheimer’s disease (AD), owing to its role in the production of neurotoxic amyloid beta (Aβ) peptides. However, despite numerous BACE1 inhibitors entering clinical trials, none have succe...
Autores principales: | Taylor, Hannah A., Simmons, Katie J., Clavane, Eva M., Trevelyan, Christopher J., Brown, Jane M., Przemyłska, Lena, Watt, Nicole T., Matthews, Laura C., Meakin, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103286/ https://www.ncbi.nlm.nih.gov/pubmed/35562959 http://dx.doi.org/10.3390/ijms23094568 |
Ejemplares similares
-
BACE1: More than just a β‐secretase
por: Taylor, Hannah A., et al.
Publicado: (2022) -
PTPRD and CNTNAP2 as markers of tumor aggressiveness in oligodendrogliomas
por: Rautajoki, Kirsi J., et al.
Publicado: (2022) -
Genetic variants in PTPRD and risk of gestational diabetes mellitus
por: Chen, Ting, et al.
Publicado: (2016) -
Application of a Bioinformatics-Based Approach to Identify Novel Putative in vivo BACE1 Substrates
por: Johnson, Joseph L, et al.
Publicado: (2013) -
Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis
por: Ortiz, Berenice, et al.
Publicado: (2014)